World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
130
Citations
68571
World Ranking
229
National Ranking
150

Medicine

D-Index
130
Citations
68808
World Ranking
2481
National Ranking
1399

Arthur M. Krieg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Arthur M. Krieg sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 409 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Arthur M. Krieg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Arthur M. Krieg sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 130 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Arthur M. Krieg is affiliated with the University of Massachusetts Chan Medical School in the United States. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with significant contributions to Oncology, Immunology, and Molecular Biology.

The main topics addressed in their work include Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Response and Inflammation, RNA Interference and Gene Delivery, CRISPR and Genetic Engineering, and DNA and Nucleic Acid Chemistry.

The scientist has an extensive publication record in several venues. Frequent publication venues include:

  • Regular and Young Investigator Award Abstracts
  • Cancer Research
  • Nucleic Acid Therapeutics
  • Cancer Cell
  • The Journal of Immunology

Frequent coauthors who have collaborated with Arthur M. Krieg are:

  • James E. Wooldridge
  • Diwakar Davar
  • Riyue Bao
  • Dmitri Bobilev
  • Jason J. Luke

Selected recent papers by Arthur M. Krieg include:

  • Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides, 2022, Nucleic Acid Therapeutics
  • Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization, 2020, The Journal of Immunology
  • Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial, 2024, Cancer Cell
  • Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in advanced melanoma, 2020, Regular and Young Investigator Award Abstracts
  • Durable responses in anti-PD-1 refractory melanoma following intratumoral injection of a toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab, 2020, Oral Presentations

Best Publications

  • CPG MOTIFS IN BACTERIAL DNA TRIGGER DIRECT B-CELL ACTIVATION

    Arthur M. Krieg;Ae-Kyung Yi;Sara Matson;Thomas J. Waldschmidt

  • CpG Motifs in Bacterial DNA and Their Immune Effects

    Arthur M Krieg

  • Therapeutic potential of Toll-like receptor 9 activation

    Arthur M. Krieg

  • CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

    Dennis M. Klinman;Ae-Kyung Yi;Serge L. Beaucage;Jacqueline Conover

  • CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.

    Rose S. Chu;Oleg S. Targoni;Arthur M. Krieg;Paul V. Lehmann

  • Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

    Marion Jurk;Florian Heil;Jörg Vollmer;Christian Schetter

  • Identification of CpG oligonucleotide sequences with high induction of IFN‐α/β in plasmacytoid dendritic cells

    Anne Krug;Simon Rothenfusser;Veit Hornung;Bernd Jahrsdörfer

  • Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.

    Z K Ballas;W L Rasmussen;A M Krieg

  • Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.

    Anne Krug;Andreas Towarowski;Stefanie Britsch;Simon Rothenfusser

  • CpG DNA Is a Potent Enhancer of Specific Immunity in Mice Immunized with Recombinant Hepatitis B Surface Antigen

    Heather L. Davis;Risini Weeranta;Thomas J. Waldschmidt;Lorraine Tygrett

  • CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.

    G. Hartmann;G. J. Weiner;A. M. Krieg

  • Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells

    Gunther Hartmann;Arthur M. Krieg;Arthur M. Krieg

  • Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo

    Gunther Hartmann;Risini D. Weeratna;Zuhair K. Ballas;Zuhair K. Ballas;Paul Payette

  • Human Plasmacytoid Dendritic Cells Activated by CpG Oligodeoxynucleotides Induce the Generation of CD4+CD25+ Regulatory T Cells

    E. Ashley Moseman;Xueqing Liang;Amanda J. Dawson;Angela Panoskaltsis-Mortari

  • Immunostimulatory nucleic acid molecules

    Arthur M. Krieg;Joel N. Kline;Dennis Klinman;Alfred D. Steinberg

  • Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.

    Jörg Vollmer;Arthur M. Krieg

  • Rapid and strong human CD8 + T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909

    Daniel E. Speiser;Danielle Liénard;Nathalie Rufer;Verena Rubio-Godoy

  • Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities

    Jörg Vollmer;Risini Weeratna;Paul Payette;Marion Jurk

  • Cutting Edge: Modulation of Airway Inflammation by CpG Oligodeoxynucleotides in a Murine Model of Asthma

    Joel N. Kline;Thomas J. Waldschmidt;Thomas R. Businga;Jennifer E. Lemish

  • Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

    George J. Weiner;Hsin-Ming Liu;James E. Wooldridge;Christopher E. Dahle

Frequent Co-Authors

Heather L. Davis
Heather L. Davis Sanofi (France)
George J. Weiner
George J. Weiner University of Iowa
Alfred D. Steinberg
Alfred D. Steinberg Mitre (United States)
Gunther Hartmann
Gunther Hartmann University Hospital Bonn
Grayson B. Lipford
Grayson B. Lipford Janus Biotherapeutics (United States)
Zuhair K. Ballas
Zuhair K. Ballas University of Iowa
Lorne A. Babiuk
Lorne A. Babiuk University of Alberta
George Mutwiri
George Mutwiri University of Saskatchewan
John M. Kirkwood
John M. Kirkwood University of Pittsburgh
Bruce R. Blazar
Bruce R. Blazar University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your knowledge through related healthcare fields can open up diverse career opportunities. Many students consider transitioning into nursing, where strong immunology knowledge is valuable. There are numerous options available, including online nursing programs for non nurses, designed specifically for individuals making a career switch without prior nursing education.

If you're looking for quicker paths to enter the nursing profession, exploring the easiest accelerated nursing programs to get into can be a smart strategy. These programs help you gain essential skills and certifications at an increased pace, preparing you to work in clinical or research settings that align with immunology principles.

For those aiming at more hands-on roles, which lpn programs are easiest to get into is a useful resource. Licensed Practical Nurse programs provide practical training and quick entry into the healthcare workforce, often involving immunological care components.

Lastly, advancing your career as a nurse practitioner is a compelling choice. The easiest np program options outline pathways that balance accessibility and career growth, allowing you to specialize in areas closely related to immunology.

Best Scientists Citing Arthur M. Krieg

Trending Scientists

Recently Published Articles